Find a Provider

Jakub Svoboda, MD

Jakub Svoboda, MD Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Languages spoken:

  • Czech

Dr. Svoboda is a Penn Medicine employed physician.

Clinical Specialties

Specialties:

  • Medicine
    • Hematology
    • Medical Oncology

Programs & Services:

  • Cancer
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Leukemia
    • Lymphoma
  • Hematology-Oncology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Hematology, 2007
  • Medical Oncology, 2006

Conditions & Treatments:

  • allogeneic transplant
  • autologous transplant
  • Blood Cancer
  • bone marrow transplant
  • Cancer Clinical Trials
  • cancer therapy
  • chronic lymphocytic leukemia
  • Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
  • cutaneous lymphoma
  • cutaneous T-cell lymphoma
  • Hodgkin Lymphoma
  • Hodgkin's lymphoma
  • lesbian, gay and bisexual health (LGBT)
  • Lymphoma
  • Non-Hodgkin Lymphoma
  • non-Hodgkin's lymphoma
  • stem cell transplant

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Yale University School of Medicine
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania

Memberships

American College of Physicians, National American Society of Clinical Oncology, National American Society of Hematology, National

Affiliation

Dr. Svoboda is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Huntington Scott F, Svoboda Jakub, Doshi Jalpa A: Cost-Effectiveness Analysis of Routine Surveillance Imaging of Patients With Diffuse Large B-Cell Lymphoma in First Remission. Journal of Clinical Oncology 33 (13): 1467-74,2015.

Mato Anthony R, Foon Kenneth A, Feldman Tatyana, Schuster Stephen J, Svoboda Jakub, Chow Kar Fai, Valentinetti Marisa, Mrkulic Mary, Azzollini Kelly, Gadaleta Gabriella, Bhattacharyya Pritish K, Zenreich Joshua, Pascual Lauren-Nicole, Yannotti Kara, Kdiry Sabrina, Howlett Christina, Strelec Lauren, Porter David, Bejot Coleen, Goy André: Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. American Journal of Hematology : 2015.

Chong Elise A, Ahmadi Tahamtan, Aqui Nicole, Svoboda Jakub, Nasta Sunita D, Mato Anthony R, Walsh Kristy M, Schuster Stephen J: Combination of lenalidomide and rituximab overcomes rituximab-resistance in patients with indolent B-cell and mantle cell lymphomas. Clinical Cancer Research : 2015.

Huntington Scott F, Nasta Sunita D, Schuster Stephen J, Doshi Jalpa A, Svoboda Jakub: Utility of interim and end-of-treatment FDG-PET/CT in frontline therapy of patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma : 1-19,2015.

Shah Nirav N, Harrison Neil, Stonecypher Mark, Frank Dale, Amorosa Valerianna, Svoboda Jakub: Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis. Clinical lymphoma, myeloma & leukemia 14 (5): e157-60,2014.

Nagle Sarah J, Chong Elise A, Chekol Seble, Shah Nirav N, Nasta Sunita D, Glatstein Eli, Plastaras John P, Torigian Drew A, Schuster Stephen J, Svoboda Jakub: The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma. Cancer Medicine 4 (1): 7-15,2014.

Academic Contact Info

Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 614-1846
Fax: (215) 615-5888
Patient appointments: 800-789-PENN (7366)

Related Links